Product Description: p38-α MAPK-IN-8 (Compound 13) is a lipophilic cationic derivative. p38-α MAPK-IN-8 is cytotoxic to various tumor cells, and can induce cell cycle arrest, apoptosis, increase reactive oxygen species (ROS) production, and induce mitochondrial membrane potential depolarization. The antitumor activity of p38-α MAPK-IN-8 may be related to p38α MAPK pathway, which can be used in the study of cancer[1].
Formula: C49H62BrO4P
References: [1]An RF, et al. Design, synthesis and cytotoxic activity of novel lipophilic cationic derivatives of diosgenin and sarsasapogenin. Bioorg Med Chem Lett. 2025 Jan 6;119:130094.
Molecular Weight: 825.89
Research Area: Cancer
Target: Apoptosis;p38 MAPK;Reactive Oxygen Species